Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, PR China; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha 410078, PR China.
Shenzhen Center for Chronic Disease Control, Shenzhen 518020, PR China.
Biomed Pharmacother. 2020 May;125:109875. doi: 10.1016/j.biopha.2020.109875. Epub 2020 Feb 6.
Efficient DNA repair is critical for cell survival following exposure to DNA topoisomerase I (Top1) inhibitors camptothecin, a nature product from which the common chemotherapeutic drugs irinotecan and topotecan are derived. The camptothecin-derived agents exert their antitumor activities by specifically stabilizing the Top1-DNA covalent complexes (Top1cc) and blocking the DNA religation step. When exposed to these DNA damage agents, tumor cells quickly activate DNA damage response. This allows sufficient time to remove the Top1ccs and prevent tumor cells from apoptosis. Several repair pathways have been implicated in this process. One of the most relevant repair modes is DNA single strand break repair (SSBR) pathway. The expression level or mutagenesis of specific repair factors involved in SSBR pathway may play an indispensable role in individual's capacity of repairing camptothecin induced DNA damage. Therefore, understanding of the tolerance pathways counteracted to camptothecin cytotoxicity is crucial in alleviating chemotherapy resistance. This review focus on the SSBR pathway in repair camptothecin induced DNA damage, aiming to provide insights into the potential molecular determinants of camptothecin chemosensitivity.
高效的 DNA 修复对于细胞在暴露于 DNA 拓扑异构酶 I(Top1)抑制剂喜树碱后存活至关重要,喜树碱是一种天然产物,由此衍生出了常见的化疗药物伊立替康和拓扑替康。喜树碱类药物通过特异性稳定 Top1-DNA 共价复合物(Top1cc)并阻断 DNA 连接步骤来发挥其抗肿瘤活性。当暴露于这些 DNA 损伤剂时,肿瘤细胞会迅速激活 DNA 损伤反应。这为清除 Top1ccs 并防止肿瘤细胞凋亡提供了足够的时间。有几个修复途径参与了这个过程。其中最相关的修复模式之一是 DNA 单链断裂修复(SSBR)途径。参与 SSBR 途径的特定修复因子的表达水平或突变可能在个体修复喜树碱诱导的 DNA 损伤的能力中发挥不可或缺的作用。因此,了解与喜树碱细胞毒性相抗衡的耐受途径对于减轻化疗耐药性至关重要。本文重点介绍 SSBR 途径在修复喜树碱诱导的 DNA 损伤中的作用,旨在为喜树碱化疗敏感性的潜在分子决定因素提供深入了解。